Apr 13, 2026

EMA Adds Anktiva to Additional Monitoring List in March 2026

EMA’s March 2026 additional monitoring update says Anktiva was added to the list as a new active substance, new biological, and conditionally authorised product. EMA’s published list also records products removed from the list in the same update cycle.

For PV readers, the black triangle ecosystem remains one of the clearest signals of where regulators want heightened post-authorisation attention. Inference: additions to this list are useful indicators of where close real-world monitoring is especially important.

Related Posts

Comments

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Stay Ahead of Pharmacovigilance News

Subscribe to PV Watch Daily and get the latest drug safety updates, regulatory developments, safety signals, industry alerts, and expert insights delivered straight to your inbox.